Vestcor Inc’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-3,796
Closed -$96K – 1321
2022
Q3
$96K Buy
3,796
+65
+2% +$2.28K ﹤0.01% 1078
2022
Q2
$124K Buy
3,731
+1,452
+64% +$61.7K ﹤0.01% 1014
2022
Q1
$164K Buy
2,279
+510
+29% +$36.7K 0.01% 989
2021
Q4
$162K Sell
1,769
-288
-14% -$34.4K 0.01% 925
2021
Q3
$261K Sell
2,057
-212
-9% -$30.9K 0.01% 766
2021
Q2
$377K Buy
+2,269
New +$368K 0.01% 700
2021
Q1
– Sell
-10,500
Closed -$2.1M – 1222
2020
Q4
$2.1M Buy
+10,500
New +$2.14M 0.09% 282

Other funds holding TDOC

Vestcor Inc's TDOC Position: Q4 2022 in Review

Vestcor Inc sold out of Teladoc Health (TDOC) in Q4 2022, closing a stake of 3,796 shares — an estimated $96K sold.

Vestcor Inc first reported a position in TDOC in Q4 2020 and held it in 7 quarters. The position peaked at $2.1M in Q4 2020. 443 funds tracked by Wall St. Rank hold TDOC as of Q4 2022.

  • Vestcor Inc reported no remaining Teladoc Health position as of Q4 2022 after selling out during the quarter.
  • Vestcor Inc sold 3,796 Teladoc Health shares in Q4 2022, an estimated $96K.
  • Vestcor Inc first reported a position in Teladoc Health in Q4 2020 and held it in 7 quarters.
  • Vestcor Inc's Teladoc Health position peaked at $2.1M in Q4 2020.
  • 443 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2022.

Based on Vestcor Inc's 13F filing for Q4 2022, filed 15 Feb 2023.